Why the $116 Billion PFE-AZN Deal is Dead in the Water By: InvestorPlace October 20, 2014 at 09:46 AM EDT Read More >> Related Stocks: AbbVie Apple Astrazeneca Plc ADR Pfizer Shire Plc Ads